Evernorth announced a $100 million investment through 2028 in Pharmacy Forward, an AI-powered specialty pharmacy program aimed at improving specialty pharmacy operations and patient care. The initiative focuses on using AI to streamline workflows tied to specialty dispensing and patient support. The move continues large payers’ and pharmacy operators’ shift toward internalizing data and deploying automation to reduce operational friction. For biotech partners, such programs can translate into more consistent access operations and potentially faster pathways through benefits and specialty logistics. The $100M scale suggests Evernorth sees enough near-term operational ROI to justify AI as a core capability, not an experimental overlay.